BioSpace News Archive

Genetown

EyePoint Pharmaceuticals Secures New Patient Access Agreement with Vizient Inc. for DEXYCU®DEXYCU to be available to diverse member network of Vizient, the largest GPO in the U.S.

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that it has entered into a formal three-year contract with Vizient Inc. effective today, November 1, 2019, to offer DEXYCU® with enhanced savings to Vizient’s diverse membership,

November 1, 2019
·
6 min read
Business

Orthofix Appoints Jon Serbousek as President and Chief Executive Officer

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, announced today the appointment of Jon Serbousek as President and Chief Executive Officer (CEO), effective immediately.

November 1, 2019
·
4 min read